Nairobi harbours all the ingredients for zoonotic spillover to occur between animals and people, particularly in the most densely populated areas of the city.
James B. Wood, Indiana University School of Medicine
Early test results look promising, and Pfizer has asked the FDA to review and authorize its vaccine for use in teens. That doesn’t mean putting away the face masks, though.
Building retrofits are no joke: They make dwellings healthier and more energy-efficient. And when they’re done in low-income housing, they also reduce inequality.
Meisha Ross Porter is the new chancellor of New York City’s public schools. A scholar of the politics of education touches on her background and what lies ahead.
Marios Koutsakos, The Peter Doherty Institute for Infection and Immunity
Scientists around the world are trying to come up with universal coronavirus vaccines to combat the emergence of variants. But what are these vaccines and are they even possible?
One way to help children learn the words they need to thrive academically is by reading aloud from books and news sources that use both narrative and expository writing.
The mental health effects of the pandemic will likely outlive COVID-19. The goal should be to target mental health symptoms early in order to decrease major long-term effects.
People with schizophrenia are almost three times more likely to die from COVID-19 than those without the serious mental illness, making it second only to age as a risk factor for mortality.
Americans were tired of social distancing and mask-wearing. At the first hint the virus was receding, people pushed to get life back to normal. Unfortunately another surge of the disease followed.
AstraZeneca just announced results from its US-based trial. It found the vaccine to be 79% effective and safe for use, despite recent concerns around reports of blood clots.
Honorary Enterprise Professor, School of Population and Global Health, and Department of General Practice and Primary Care, The University of Melbourne
Dean Faculty of Health Sciences and Professor of Vaccinology at University of the Witwatersrand; and Director of the SAMRC Vaccines and Infectious Diseases Analytics Research Unit, University of the Witwatersrand